Subcutaneous versus intravenous double-dose infliximab for dose intensification in young adults with Crohn's disease: a prospective comparative study

Digestive and Liver Disease · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles